Costa poco antenna Offesa lxr agonist clinical trial giungla Guerriero Nuovo arrivo
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice* - Journal of Biological Chemistry
Liver X receptors in lipid metabolism: opportunities for drug discovery - Document - Gale Academic OneFile
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology
Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR - ScienceDirect
Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol‐Induced Cardiac Damage | Journal of the American Heart Association
Molecules | Free Full-Text | Ligands of Therapeutic Utility for the Liver X Receptors | HTML
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library